Inflammatory conditions like IBD, Crohn’s disease [78], colitis, and cancerous genetic mutations like the adenomatous polyposis coli gene (APCmin/+), mismatch repair gene (Msh2–/–), and B-Raf proto-oncogene (BRAF) mutations are often associated with pro-oncogenic gut microbiota that may include bacteria like enterotoxigenic Bacteroides fragilis (ETBF) [45,46] and Fn [79,80,81]. The gene discussed is BRAF; the disease is inflammatory bowel disease.